Privium Fund Management (Uk) LTD Avrobio, Inc. Transaction History

Privium Fund Management (Uk) LTD

  • $54.9 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023
SELL
$0.76 - $1.82 $133,405 - $319,471
-175,534 Reduced 66.67%
87,770 $87,000
Q4 2022

Feb 09, 2023
BUY
$0.64 - $0.91 $98,370 - $139,870
153,704 Added 140.24%
263,304 $186,000
Q3 2022

Nov 01, 2022
BUY
$0.68 - $1.11 $74,528 - $121,656
109,600 New
109,600 $70,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Privium Fund Management (Uk) LTD Portfolio

Follow Privium Fund Management (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Privium Fund Management (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Privium Fund Management (Uk) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email